![Alessandro Sidoli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alessandro Sidoli
Fondateur chez Axxam SpA
Postes actifs de Alessandro Sidoli
Sociétés | Poste | Début | Fin |
---|---|---|---|
Externautics SpA
![]() Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Directeur/Membre du Conseil | - | - |
Axxam SpA
![]() Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Directeur/Membre du Conseil | 01/01/2001 | - |
Directeur Général | 01/01/2001 | - | |
Fondateur | 01/01/2001 | - | |
Federazione Nazionale dell'Industria Chimica | Directeur/Membre du Conseil | - | - |
Italian Association of Business Angels | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
IMAX Discovery GmbH
![]() IMAX Discovery GmbH Food: Specialty/CandyConsumer Non-Durables Part of IMAX Corp., IMAX Discovery GmbH develops novel and natural flavor compounds for the food and beverage industry. The company is based in Dortmund, Germany. The CEO of the German company is Alessandro Sidoli. | Directeur Général | - | - |
Historique de carrière de Alessandro Sidoli
Anciens postes connus de Alessandro Sidoli
Sociétés | Poste | Début | Fin |
---|---|---|---|
XBRANE BIOPHARMA AB | Directeur/Membre du Conseil | 01/01/2016 | 16/05/2019 |
Independent Dir/Board Member | 01/01/2016 | 16/05/2019 | |
Istituto Sieroterapico Milanese | Corporate Officer/Principal | - | - |
Primm SRL
![]() Primm SRL BiotechnologyHealth Technology Primm SRL engages in the manufacturing, marketing and sale of biotech services. It offers poly and monoclonal antibodies, peptides, DNA synthesis, DNA sequencing, protein analysis, gene cloning, recombinant protein and pharmacological and toxicological services. The firm provides research and development activities which focuses on the design, synthesis, and pharmaceutical development of bioactive peptides for therapeutical applications. The company was founded by Sidoli Alessandro in 1990 and is based in Milan, Italy. | Président | 22/06/2011 | - |
Fondateur | 22/06/2011 | - |
Formation de Alessandro Sidoli
University of Pavia | Undergraduate Degree |
Statistiques
Internationale
Italie | 8 |
Suède | 2 |
Allemagne | 2 |
Opérationnelle
Director/Board Member | 5 |
Founder | 3 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
XBRANE BIOPHARMA AB | Health Technology |
Entreprise privées | 7 |
---|---|
Externautics SpA
![]() Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Health Technology |
Primm SRL
![]() Primm SRL BiotechnologyHealth Technology Primm SRL engages in the manufacturing, marketing and sale of biotech services. It offers poly and monoclonal antibodies, peptides, DNA synthesis, DNA sequencing, protein analysis, gene cloning, recombinant protein and pharmacological and toxicological services. The firm provides research and development activities which focuses on the design, synthesis, and pharmaceutical development of bioactive peptides for therapeutical applications. The company was founded by Sidoli Alessandro in 1990 and is based in Milan, Italy. | Health Technology |
Axxam SpA
![]() Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Commercial Services |
Federazione Nazionale dell'Industria Chimica | |
Italian Association of Business Angels | |
IMAX Discovery GmbH
![]() IMAX Discovery GmbH Food: Specialty/CandyConsumer Non-Durables Part of IMAX Corp., IMAX Discovery GmbH develops novel and natural flavor compounds for the food and beverage industry. The company is based in Dortmund, Germany. The CEO of the German company is Alessandro Sidoli. | Consumer Non-Durables |
Istituto Sieroterapico Milanese |
- Bourse
- Insiders
- Alessandro Sidoli
- Expérience